1h Free Analyst Time
The porcine vaccine market is forecasted to grow by USD 709.6 million during 2023-2028, accelerating at a CAGR of 6.4% during the forecast period. The report on the porcine vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of porcine diseases, increase in research and development expenditure for development of porcine vaccines, and growing animal healthcare expenditure.
The porcine vaccine market is segmented as below:
By Product
- Intravenous
- Intramuscular
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the porcine vaccine market covers the following areas:
- Porcine Vaccine Market sizing
- Porcine Vaccine Market forecast
- Porcine Vaccine Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global porcine vaccine market: Bimeda Holdings Ltd., Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., FATRO SpA, Formosa Biomedical Inc., HIPRA SA, Merck and Co. Inc., Phibro Animal Health Corp., Veterinary Provisions Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing demand for pork and gelatin."
According to the report, one of the major drivers for this market is the increasing prevalence of porcine diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bimeda Holdings Ltd.
- Bioveta AS
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco Animal Health Inc.
- FATRO SpA
- Formosa Biomedical Inc.
- HIPRA SA
- Merck and Co. Inc.
- Phibro Animal Health Corp.
- Veterinary Provisions Inc.
- Vetoquinol SA
- Virbac Group
- Zoetis Inc.
